Yüklüyor......
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
The frequency of using rituximab to treat refractory nephrotic syndrome has recently been increasing, and the conventional dose of rituximab used to treat it, 375 mg/m2 body surface area once weekly for 4 weeks, has been modelled on the chemotherapy regimen for B-cell non-Hodgkin’s lymphoma. The dos...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Karger Publishers
2018-10-01
|
| Seri Bilgileri: | Case Reports in Nephrology and Dialysis |
| Konular: | |
| Online Erişim: | https://www.karger.com/Article/FullText/493189 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|